Specialised Medication - Rituximab Guideline

Name/Title

Specialised Medication - Rituximab Guideline (PDF)

Document ID

TS4KSNFPVEZQ-89-5489

Current from

07/11/2016

Coverage

WACHS

Policy Type

Guideline

Summary

Provides guidance for the prescription and administration of rituximab when being used for rheumatoid arthritis only. If rituximab is being used as an anti-neoplastic agent, please refer to the appropriate guideline for that specific indication. Information in this guideline is specific to Mabthera.

FEEDBACK

ON OUR SERVICES

FEEDBACK

ABOUT THIS WEBSITE